Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

801
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
801
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

757
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
757
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

890
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
890
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

364
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
364
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

414
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
414

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping the LVAD landscape: insights from the ITAMACS registry.

European journal of heart failure·2026
Same authorSame journal

A machine learning model for early risk stratification of 28-day mortality after myocardial infarction.

European heart journal. Digital health·2026
Same author

QutRNA2: robust tRNA modification discovery from Nanopore direct tRNA sequencing.

NAR genomics and bioinformatics·2026
Same author

Systemic CXCL4 Levels and Clinical Outcomes in Acute Ischemic Stroke.

Current neurovascular research·2026
Same author

The Anatomy of a Failed DiGA: Taxonomic Insights from Withdrawn Reimbursable Digital Therapeutics.

Studies in health technology and informatics·2026
Same author

Editorial: listening for congestion in heart failure.

European heart journal. Digital health·2026

Related Experiment Video

Updated: Jan 17, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.0K

The 'Advancing Cardiovascular Risk Identification with Structured Clinical Documentation and Biosignal Derived

Dominik Felbel1, Merten Prüser2,3, Constanze Schmidt4

  • 1Department of Cardiology, Ulm University Heart Center, Ulm, Germany.

European Heart Journal. Digital Health
|September 23, 2025
PubMed
Summary

The ACRIBiS project enhances cardiovascular risk assessment by integrating routine clinical data and high-resolution biosignals. This improves personalized prevention and patient empowerment through standardized data and innovative tools.

Keywords:
ACRIBiSBiosignalsCardiovascular risk scoresInteroperabilityPersonalized risk predictionSecondary use

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.0K

Related Experiment Videos

Last Updated: Jan 17, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.0K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.0K

Area of Science:

  • Cardiovascular medicine
  • Medical informatics
  • Health data interoperability

Background:

  • Personalized risk assessment tools (PRTs) are crucial for cardiovascular care but face poor clinical implementation.
  • Standardized documentation and biosignal integration are needed for effective PRTs.

Purpose of the Study:

  • To establish interoperable infrastructures for standardized clinical documentation and high-resolution biosignal (HRB) integration.
  • To enable data-based cardiovascular risk assessment and improve patient empowerment and prognosis.

Main Methods:

  • Selected established cardiovascular risk scores and built a core dataset with risk-relevant clinical information.
  • Developed an extension module for interoperability and implemented modular ECG processing infrastructure for HRB integration.
  • Evaluated PRT predictive performance and dynamic recalibration using HRB integration in a 5250-patient cohort over 12 months.

Main Results:

  • The ACRIBiS project harmonizes clinical data documentation and integrates ECG data for enhanced risk assessment.
  • Developed consensus-based specifications for standardized routine patient data collection.
  • The ACRIBiS cohort dataset will be available for broad secondary use.

Conclusions:

  • The ACRIBiS project facilitates personalized cardiovascular risk assessment through harmonized data and biosignal integration.
  • Standardized documentation and interoperability specifications support national and international data collection.
  • The project aims to improve patient empowerment and cardiovascular prognosis.